(0.09%) 5 211.25 points
(0.08%) 39 027 points
(-0.07%) 18 182 points
(-0.55%) $78.05
(-0.64%) $2.18
(-0.27%) $2 324.90
(-0.02%) $27.61
(2.15%) $985.65
(-0.02%) $0.928
(0.30%) $10.86
(0.09%) $0.797
(-0.10%) $91.26
0.96% $ 17.84
@ $15.21
Wydano: 13 vas. 2024 @ 16:42
Zwrot: 17.29%
Poprzedni sygnał: vas. 9 - 16:30
Poprzedni sygnał:
Zwrot: 3.75 %
Live Chart Being Loaded With Signals
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 88 698.00 |
Średni wolumen | 244 665 |
Kapitalizacja rynkowa | 543.28M |
EPS | $0 ( 2024-03-27 ) |
Następna data zysków | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.63 |
ATR14 | $0.0410 (0.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-26 | Sullivan Brian F. | Sell | 45 025 | Common Stock |
2024-04-26 | Sullivan Brian F. | Buy | 45 025 | Common Stock |
2024-04-24 | Buller Richard E | Sell | 350 | Common Stock |
2024-04-08 | Buller Richard E | Buy | 19 558 | Stock Option (right to buy) |
2024-04-08 | Buller Richard E | Buy | 12 654 | Stock Option (right to buy) |
INSIDER POWER |
---|
8.70 |
Last 100 transactions |
Buy: 4 121 398 | Sell: 3 000 264 |
Wolumen Korelacja
Celcuity Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
NICE | 0.919 |
LNW | 0.91 |
NOTV | 0.906 |
CROX | 0.904 |
DVOL | 0.895 |
PCAR | 0.895 |
BRKR | 0.895 |
CPRT | 0.894 |
DAX | 0.892 |
EBIZ | 0.892 |
10 Najbardziej negatywne korelacje | |
---|---|
NH | -0.872 |
IRDM | -0.846 |
VORB | -0.841 |
DCRC | -0.841 |
PEAR | -0.84 |
DPRO | -0.84 |
LAWS | -0.836 |
SABR | -0.835 |
TCFC | -0.834 |
PYR | -0.834 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Celcuity Inc Korelacja - Waluta/Towar
Celcuity Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-142 772 (0.00 %) |
EPS: | $-2.69 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-142 772 (0.00 %) |
EPS: | $-2.69 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-210 918 (0.00 %) |
EPS: | $-2.68 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.88 |
Financial Reports:
No articles found.
Celcuity Inc
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej